New hope for advanced cancers? first human trial of PMC-309 begins

NCT ID NCT05957081

Recruiting now Disease control Sponsor: PharmAbcine Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests a new drug called PMC-309, alone or with another drug (pembrolizumab), in people with advanced solid tumors that have not responded to other treatments. The main goal is to check safety and find the best dose. About 67 adults will take part.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED OR METASTATIC SOLID TUMORS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

metastatic malignant neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED OR METASTATIC SOLID TUMORS

Contacts and locations

Locations

Alfred Health
RECRUITING

Melbourne, Victoria, 3004, Australia
Australian Hospital Care (Pindara) PTY LTD. Trading as Pindara Private Hospital
RECRUITING

Benowa, Queensland, 4217, Australia
Ballarat Regional Integrated Cancer Centre (Grampians Health)
RECRUITING

Ballarat, Victoria, 3350, Australia
Cabrini Health Limited
RECRUITING

Malvern, Victoria, 3144, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.